http://www.pharmaceutical-technology.com/news/ec-approves-sanofi-dupixent/
0
0
12/16/22 at 7:04am
Organization
Pharmaceutical Technology
Author
Vishnu Priyan
The EC has granted expanded marketing authorisation for Sanofi’s Dupixent (dupilumab) for the treatment of prurigo nodularis in adults.
Create an account
or login to join the discussion